"Night Vision and Carotenoids"
Completed · Not applicable · Has a placebo group
Conditions studied: Macular Degeneration
In brief
Vision at twilight and night is more difficult and dangerous for the entire population, even more so for the elderly and especially for the elderly with degenerative disease. Multiple worldwide laboratories have demonstrated the ability to raise macular pigment optical density with dietary carotenoids. This proposal further evaluates the relationship between macular re- pigmentation and vision under stressed conditions simulating twilight and night driving.
Key facts
- Study ID
- NCT04741763
- Run by
- Robert Davis
- People needed
- 27
- Starts
- 2018-02-13
- Expected to finish
- 2020-08-20
- Last updated by the study team
- 2021-02-05
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- No significant supplementary carotenoids within last 10 weeks. Without significant media opacity, cataract or congenital / acquired retinal disease other than atrophic AMD or diabetic retinopathy. Minimum 20/25 to enroll.
You may not qualify if…
- Unwilling or medically / psychiatrically unable to take part in a 6 month study.
- Recent ophthalmologic surgery or treatment.
- Tricare, Retirees \& Enlisted Navy Personnel excluded. Already taking an OTC product to improve their night vision (containing carotenoids, polyphenols like bilberry).
Where it is running
- The Captain James A. Lovell Federal Health Care Center (FHCC) — North Chicago, Illinois, United States
- Davis EyeCare — Oak Lawn, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.